• Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
Friday, November 20, 2026
No Result
View All Result
Subscribe Now
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    Texas Execution Prolonged As Staff Encounter Difficulties Finding Vein, Inmate Reinaldo Dennes Reports Pain

    Texas Execution Prolonged As Staff Encounter Difficulties Finding Vein, Inmate Reinaldo Dennes Reports Pain

    Trump’s Deal Turns Sour as Voters Withdraw Support

    Trump’s Deal Turns Sour as Voters Withdraw Support

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
The Insight Post
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    Texas Execution Prolonged As Staff Encounter Difficulties Finding Vein, Inmate Reinaldo Dennes Reports Pain

    Texas Execution Prolonged As Staff Encounter Difficulties Finding Vein, Inmate Reinaldo Dennes Reports Pain

    Trump’s Deal Turns Sour as Voters Withdraw Support

    Trump’s Deal Turns Sour as Voters Withdraw Support

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
No Result
View All Result
No Result
View All Result
Home Latest Headlines

Breakthrough Pancreatic Cancer Treatment Shows Promising Results, Doubling Patient Survival in Clinical Trial

by Theinsightpost
November 20, 2026
in Latest Headlines
0 0
0
Breakthrough Pancreatic Cancer Treatment Shows Promising Results, Doubling Patient Survival in Clinical Trial

New Drug Shows Promise in Treating Advanced Pancreatic Cancer

Recent early clinical trial results, presented at the EORTC-NCI-AACR Symposium in Barcelona, indicate that an experimental medication, daraxonrasib, when used in conjunction with standard chemotherapy, has effectively reduced tumor size or halted tumor growth in a significant majority of patients suffering from advanced pancreatic cancer.

Trial Overview and Patient Demographics

This phase 1/2 trial involved 61 patients who had advanced pancreatic cancer that had metastasized to other organs and had not previously undergone treatment for their condition. The study focused on the combination of daraxonrasib, administered orally on a daily basis, alongside two conventional intravenous chemotherapy agents: gemcitabine and nab-paclitaxel.

Impact of the Combination Therapy

Pancreatic cancer is known for its challenging treatment landscape, primarily because over half of the patients are diagnosed only after the disease has spread. Historically, major clinical trials show that chemotherapy alone reduces tumor size in approximately 23% to 42% of patients; however, cancer growth often resumes within five to six months, with an average survival rate of 8 to 11 months post-diagnosis.

In the recent study, which had a median follow-up of 18 months, tumors shrank in 60.7% of the cases, with complete disappearance in 8.2% of participants, while the combination therapy successfully halted tumor growth in 90.2% of the cohort.

Survival Rates and Efficacy

Patients experienced a median duration of 12.8 months before their condition worsened, nearly double the typical duration observed with standard chemotherapy. Additionally, 76.6% of the patients remained alive at the one-year follow-up mark.

Dr. Wungki Park, a gastrointestinal medical oncologist at Memorial Sloan Kettering Cancer Center and the study’s lead investigator, stated, “We are now seeing not only substantial tumor shrinkages, including complete responses, but also durable disease control, with median progression-free survival exceeding one year.”

Safety and Side Effects

While the treatment regimen led to some manageable side effects such as rash, diarrhea, fatigue, and low blood cell counts, only 5% of the participants discontinued the treatment due to adverse effects associated with daraxonrasib.

Mechanism of Action and Future Directions

Pancreatic cancers are predominantly driven by a malfunctioning gene known as RAS, which promotes continuous tumor growth. Daraxonrasib aims to inhibit this growth signal, a breakthrough that many researchers previously believed was unattainable through pharmacological means.

Dr. Elena Garralda, chair of the symposium and co-director of the clinical research program at the Vall d’Hebron Institute of Oncology in Spain, noted that the results suggest that RAS-targeted therapies can be effectively integrated with existing treatments from the onset, potentially leading to longer-lasting therapeutic benefits.

Ongoing Research and Limitations

Researchers are conducting a larger, randomized Phase 3 trial, named RASolute-303, to directly compare the efficacy of daraxonrasib—both alone and in combination with chemotherapy—against standard chemotherapy. It is important to note that the current findings apply specifically to metastatic pancreatic cancer, and further studies will be required to explore the drug’s effectiveness in other cancers driven by similar RAS mutations.

The trial received funding from Revolution Medicines, the California-based company developing daraxonrasib, highlighting the potential of this new treatment approach in the ongoing battle against pancreatic cancer.

ShareTweetSend
Previous Post

Exciting Sneak Peeks: What to Expect on DAYS During the Week of November 23

Related News

Tragic Loss: Dallas Cowboys Fan Passes Away Following Incident at AT&T Stadium
Latest Headlines

Tragic Loss: Dallas Cowboys Fan Passes Away Following Incident at AT&T Stadium

November 20, 2026
DOJ Backs OpenAI in Landmark Copyright Dispute with Media Outlets
Latest Headlines

DOJ Backs OpenAI in Landmark Copyright Dispute with Media Outlets

November 20, 2026
Texas Execution of Inmate Reinaldo Dennes Raises Concerns After 63 Minutes of Distress
Latest Headlines

Texas Execution of Inmate Reinaldo Dennes Raises Concerns After 63 Minutes of Distress

November 20, 2026
Aidan Hutchinson Speaks Out Following Season-Ending Injury and Reveals His Celebration Plans
Latest Headlines

Aidan Hutchinson Speaks Out Following Season-Ending Injury and Reveals His Celebration Plans

November 19, 2026

Discussion about this post

Subscribe To Our Newsletters

    Customer Support


    1251 Wilcrest Drive
    Houston, Texas
    77042 USA
    Call-832.795.1420
    e-mail – news@theinsightpost.com

    Subscribe To Our Newsletters

      Categories

      • Africa
      • Africa-East
      • African Sports
      • American Sports
      • Arts
      • Asia
      • Australia
      • Business
      • Business Asia
      • Business- Africa
      • Canada
      • Defense
      • Education
      • Egypt
      • Energy
      • Entertainment
      • Europe
      • European Soccer
      • Finance
      • Germany
      • Ghana
      • Health
      • Insight
      • International
      • Investing
      • Japan
      • Latest Headlines
      • Life & Living
      • Markets
      • Mobile
      • Movies
      • New Zealand
      • Nigeria
      • Politics
      • Scholarships
      • Science
      • South Africa
      • South America
      • Sports
      • Tech
      • Travel
      • Travel-Africa
      • UK
      • USA
      • Weather
      • World
      No Result
      View All Result

      Recent News

      Breakthrough Pancreatic Cancer Treatment Shows Promising Results, Doubling Patient Survival in Clinical Trial

      Breakthrough Pancreatic Cancer Treatment Shows Promising Results, Doubling Patient Survival in Clinical Trial

      November 20, 2026
      Exciting Sneak Peeks: What to Expect on DAYS During the Week of November 23

      Exciting Sneak Peeks: What to Expect on DAYS During the Week of November 23

      November 20, 2026
      Bridging the Healthcare Gap: Enhancing Access for Rural Communities

      Bridging the Healthcare Gap: Enhancing Access for Rural Communities

      November 20, 2026
      CNN’s Harry Enten Cautions Democrats: Focus on Voter Issues Over Trump Investigations

      CNN’s Harry Enten Cautions Democrats: Focus on Voter Issues Over Trump Investigations

      November 20, 2026
      • Home
      • Advertise With Us
      • About Us
      • Corporate
      • Consumer Rewards
      • Forum
      • Privacy Policy
      • Social Trends

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      Welcome Back!

      Login to your account below

      Forgotten Password?

      Retrieve your password

      Please enter your username or email address to reset your password.

      Log In

      Add New Playlist

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in .

      No Result
      View All Result
      • Home
      • Insight
      • Blog
      • Business
      • Entertainment
      • Health
      • Politics
      • Shop
        • Gift Shop
        • Value Shop
        • Store
        • Bargain Shop
        • Discount
      • Sports
      • Tech
      • Travel
      • USA
      • Video
      • World
        • Asia
        • Africa
        • South America
        • North America
        • Europe
        • Oceania

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      The Insight Post
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      Cookie Policy

      More information about our Cookie Policy